AU403: Novel selective LXRβ-PPAR selective agonist for Alzheimer’s Disease
- Raj Amin
- Jan 1, 2023
- 1 min read
AU403 helps mitigate ADRD, including APOe4 patients, develop neurodegeneration due to dysregulation of neuro-metabolism and neuro- cholesterol that induces aggregation of proteins, neuroinflammation and pathological hallmarks that lead to neurodegeneration.
